"Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative" Pharmacodynamics, Pharmacokinetics and Pharmacogenomics study

Trial Profile

"Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative" Pharmacodynamics, Pharmacokinetics and Pharmacogenomics study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Breast cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Mar 2016 Status changed from recruiting to active, no longer recruiting.
    • 12 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top